FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $14.63 million.
GUIDANCE:
Apyx Medical Corp. sees FY2022 revenue of $50-63 million, versus the... More

